AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Memo

Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo. AsiaTIDES 2019 keynote presentation lineup: 1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S 2) New Strategies and Technologies in Oligonucleotide Therapeutic Development- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals 3) The Chemistry behind Approved Oligonucleotide Therapeutics- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc. 4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences Prices:Conference Pass + Pre-Conference Workshop: USD 3023.0,Conference Pass: USD 2375.0 Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences Time: 9:00 am - 5:00 pm Venue details: Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-0031, Japan